neonate and paediatrics During 2022, the majority of the simulation revenues came from our ScanTrainer, HeartWorks and BodyWorks platforms. In 2023 it is anticipated. | April 20, 2023
ANGLE ACHIEVES WORLD FIRST WITH FDA CLEARANCE FOR ITS PARSORTIX SYSTEMFDA De Novo product clearance to harvest cancer cells from blood for subsequent analysis offers the prospect of a new era of personalised
ANGLE receives FDA clearance for Parsortix phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.